Australian Broker Call *Extra* Edition – Oct 21, 2025

Array
(
    [0] => Array
        (
            [0] => ((29M))
            [1] => ((29M))
            [2] => ((A2M))
            [3] => ((ABB))
            [4] => ((AGN))
            [5] => ((AIA))
            [6] => ((ANZ))
            [7] => ((WBC))
            [8] => ((NAB))
            [9] => ((CBA))
            [10] => ((ARL))
            [11] => ((BLX))
            [12] => ((BOQ))
            [13] => ((BRI))
            [14] => ((CEN))
            [15] => ((CPU))
            [16] => ((EGG))
            [17] => ((ERD))
            [18] => ((EVN))
            [19] => ((FCL))
            [20] => ((GEM))
            [21] => ((JIN))
            [22] => ((MTM))
            [23] => ((NDO))
            [24] => ((ORA))
            [25] => ((SPG))
            [26] => ((TLX))
            [27] => ((TLX))
            [28] => ((TTM))
        )

    [1] => Array
        (
            [0] => 29M
            [1] => 29M
            [2] => A2M
            [3] => ABB
            [4] => AGN
            [5] => AIA
            [6] => ANZ
            [7] => WBC
            [8] => NAB
            [9] => CBA
            [10] => ARL
            [11] => BLX
            [12] => BOQ
            [13] => BRI
            [14] => CEN
            [15] => CPU
            [16] => EGG
            [17] => ERD
            [18] => EVN
            [19] => FCL
            [20] => GEM
            [21] => JIN
            [22] => MTM
            [23] => NDO
            [24] => ORA
            [25] => SPG
            [26] => TLX
            [27] => TLX
            [28] => TTM
        )

)

This story features 29METALS LIMITED, and other companies.
For more info SHARE ANALYSIS: 29M
The company is included in ALL-ORDS

An additional news report on the recommendation, valuation, forecast and opinion changes and updates for ASX-listed equities.

In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Australian Broker Call *Extra* Edition, featuring additional sources of research and insights on ASX-listed stocks, also enlarging the number of stocks that make up the FNArena universe.

One key difference is the *Extra* Edition will not be updated daily, but merely “regularly” depending on availability of suitable quality content. As such, the *Extra* Edition tries to build a bridge between daily updates via the Australian Broker Call Report and ad hoc news stories, that are not always timely for investors hungry for the next information update.

Investors using the *Extra* Edition as a source of input for their own share market research should thus take into account that information after publication may not be up to date, or yet awaiting another update by FNArena’s team of journalists.

Similar to The Australian Broker Call Report, this *Extra* Edition includes concise but limited reviews of research recently published by Stockbrokers and other experts, which should be considered as information concerning likely market behaviour rather than advice on the securities mentioned. Do not act on the contents of this Report without first reading the important information included at the end of this Report.

The Australian Broker Call *Extra* Edition is a summary that has been prepared independently of the sources identified. Readers will check the full text of the recommendations and consult a Licenced Advisor before making any investment decision.

The copyright of this Report is owned by the publisher. Readers will not copy, forward or disseminate this Report to any other person. For more vital information about the sources included, see the bottom of this Report.

COMPANIES DISCUSSED IN THIS ISSUE

Click on a symbol for fast access.
The number next to the symbol represents the number of brokers covering it for this report -(if more than 1)

29M (2)   A2M   ABB   AGN   AIA   ANZ   ARL   BLX   BOQ   BRI   CEN   CPU   EGG   ERD   EVN   FCL   GEM   JIN   MTM   NDO   ORA   SPG   TLX (2)   TTM  

29M    29METALS LIMITED

Copper – Overnight Price: $0.41

Canaccord Genuity rates ((29M)) as Sell (5) –

29Metals reported its September quarter production, which was a sizeable miss on by-product output for zinc, gold and silver due to seismic activity at Xantho.

The miner has guided to lower zinc production to 35-40kt from 60-70kt, Canaccord Genuity notes, with flat copper production for the quarter, while the miss on by-products resulted in C1 costs rising 79% on the prior quarter.

Cash declined by -18% over the quarter, and ongoing cash burn without further insurance payouts has the analyst concerned over the balance sheet and the ability to continue funding growth at Gossan Valley.

Target price falls to 25c from 30c, with no change in Sell rating.

This report was published on October 15, 2025.

Target price is $0.25 Current Price is $0.41 Difference: minus $0.16 (current price is over target).
If 29M meets the Canaccord Genuity target it will return approximately minus 39% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $0.27, suggesting downside of -33.5%(ex-dividends)
The company’s fiscal year ends in December.

Forecast for FY25:

Canaccord Genuity forecasts a full year FY25 dividend of 0.00 cents and EPS of minus 6.00 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 6.83.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is -1.0, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is N/A.

Forecast for FY26:

Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of 2.00 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 20.50.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 0.3, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 136.7.

Market Sentiment: -0.5
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

Jarden rates ((29M)) as Underweight (4) –

Jarden describes a weak September quarter for 29Metals, with management downgrading 2025 production guidance by -40% for zinc, -20% for gold, and -9% for silver.

The broker notes output from the high-grade Xantho Extended orebody (part of the Golden Grove operation) will be offline for around six months while rehabilitation and ground support works are completed following recent seismic events.

Liquidity fell by -$34m to $168m, with cash at $153m and net debt rising to $47m.

While the broker’s production forecasts are reduced for 2025-26, Jarden offsets some impact via higher commodity price assumptions.

The broker cuts its target price to 28c from 30c and maintains an Underweight rating.

This report was published on October 16, 2025.

Target price is $0.28 Current Price is $0.41 Difference: minus $0.13 (current price is over target).
If 29M meets the Jarden target it will return approximately minus 32% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $0.27, suggesting downside of -33.5%(ex-dividends)

Forecast for FY25:

Current consensus EPS estimate is -1.0, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is N/A.

Forecast for FY26:

Current consensus EPS estimate is 0.3, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 136.7.

Market Sentiment: -0.5
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

A2M    A2 MILK COMPANY LIMITED

Dairy – Overnight Price: $9.16

Jarden rates ((A2M)) as Downgrade to Underweight from Neutral (4) –

Over FY22-25, Jarden points out a2 Milk Co has delivered a strong turnaround despite structural decline in the China infant milk formula (IMF) market.

The broker revises its earnings forecasts by 2% for FY26, -1% for FY27, and 4% for FY28, reflecting updated assumptions for the new product pipeline and supply chain transformation. 

Jarden attributes 77% of its valuation to existing products and supply chain improvements, with NZ$1.85 per share reflecting future innovation.

The broker lifts its target to NZ$7.85 from NZ$7.80 and downgrades to Underweight from Neutral, viewing current valuation as fully pricing in foreseeable growth.

This report was published on October 15, 2025.

Current Price is $9.16. Target price not assessed.
Current consensus price target is $8.75, suggesting downside of -4.5%(ex-dividends)
The company’s fiscal year ends in June.

Forecast for FY26:

Jarden forecasts a full year FY26 dividend of 19.46 cents and EPS of 25.73 cents.
At the last closing share price the estimated dividend yield is 2.12%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 35.60.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 25.5, implying annual growth of N/A.
Current consensus DPS estimate is 19.0, implying a prospective dividend yield of 2.1%.
Current consensus EPS estimate suggests the PER is 35.9.

Forecast for FY27:

Jarden forecasts a full year FY27 dividend of 23.91 cents and EPS of 29.73 cents.
At the last closing share price the estimated dividend yield is 2.61%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 30.81.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 29.8, implying annual growth of 16.9%.
Current consensus DPS estimate is 39.9, implying a prospective dividend yield of 4.4%.
Current consensus EPS estimate suggests the PER is 30.7.

This company reports in NZD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.4
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

ABB    AUSSIE BROADBAND LIMITED

Telecommunication – Overnight Price: $5.85

Jarden rates ((ABB)) as Overweight (2) –

Aussie Broadband’s AGM trading update revealed 16,000 additional net subscribers to 11 October from June 30, though the implied annualised growth rate of 57,000 was softer than Jarden expected.

The broker notes elevated industry churn of -50-100bps is likely to persist through the Black Friday period due to strong promotional activity, but expects Aussie Broadband to maintain its early October momentum.

A run-rate of 90,000 annualised net adds through December is expected.

Jarden retains an Overweight rating and a $5.80 target price.

This report was published on October 15, 2025.

Target price is $5.80 Current Price is $5.85 Difference: minus $0.05 (current price is over target).
If ABB meets the Jarden target it will return approximately minus 1% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $6.26, suggesting upside of 7.0%(ex-dividends)
The company’s fiscal year ends in June.

Forecast for FY26:

Jarden forecasts a full year FY26 dividend of 7.00 cents and EPS of 24.50 cents.
At the last closing share price the estimated dividend yield is 1.20%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 23.88.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 19.8, implying annual growth of 76.9%.
Current consensus DPS estimate is 6.4, implying a prospective dividend yield of 1.1%.
Current consensus EPS estimate suggests the PER is 29.5.

Forecast for FY27:

Jarden forecasts a full year FY27 dividend of 11.00 cents and EPS of 33.90 cents.
At the last closing share price the estimated dividend yield is 1.88%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 17.26.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 26.2, implying annual growth of 32.3%.
Current consensus DPS estimate is 8.1, implying a prospective dividend yield of 1.4%.
Current consensus EPS estimate suggests the PER is 22.3.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

AGN    ARGENICA THERAPEUTICS LIMITED

Pharmaceuticals & Biotech/Lifesciences – Overnight Price: $0.27

Petra Capital rates ((AGN)) as Buy (1) –

Management at Argenica Therapeutics announced new data from its Phase 2 stroke trial showing ARG-007 patients achieved better functional outcomes than the placebo group.

Improvements were observed across cognition, independence, and quality of life, with strong gains on the Barthel Index (used to measure ability to perform basic activities of daily living) between Day 30 and 90, highlights Petra Capital.

The analyst views the results as highly encouraging given poorer baseline characteristics in the treated group. Additional analysis through Brainomix imaging will refine the Phase 2b trial design, expected to begin in 2H 2026.

The broker keeps its Buy rating and 63c target price.

This report was published on October 16, 2025.

Target price is $0.63 Current Price is $0.27 Difference: $0.36
If AGN meets the Petra Capital target it will return approximately 133% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.

Forecast for FY26:

Petra Capital forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 3.50 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 7.71.

Forecast for FY27:

Petra Capital forecasts a full year FY27 dividend of 0.00 cents and EPS of minus 6.60 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 4.09.

All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

AIA    AUCKLAND INTERNATIONAL AIRPORT LIMITED

Infrastructure & Utilities – Overnight Price: $7.12

Jarden rates ((AIA)) as Neutral (3) –

Auckland International Airport remains on track to meet its FY26 passenger volume guidance, according to Jarden, supported by forward scheduling trends and the first quarter result.

The broker’s analysis suggests volume forecasts are achievable based on current seat capacity projections through FY26, with recent Jetstar announcements adding around 490,000 annual seats.

While this provides modest upside potential, Jarden warns operational risks remain given monthly volatility and seasonality.

The broker makes minor model adjustments, lifting its target price to NZ$7.93 from NZ$7.81, and maintains a Neutral rating.

This report was published on October 16, 2025.

Current Price is $7.12. Target price not assessed.
Current consensus price target is N/A
The company’s fiscal year ends in June.

Forecast for FY26:

Jarden forecasts a full year FY26 dividend of 12.09 cents and EPS of 15.73 cents.
At the last closing share price the estimated dividend yield is 1.70%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 45.27.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 16.1, implying annual growth of N/A.
Current consensus DPS estimate is 11.6, implying a prospective dividend yield of 1.6%.
Current consensus EPS estimate suggests the PER is 44.2.

Forecast for FY27:

Jarden forecasts a full year FY27 dividend of 12.73 cents and EPS of 18.27 cents.
At the last closing share price the estimated dividend yield is 1.79%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 38.96.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 16.9, implying annual growth of 5.0%.
Current consensus DPS estimate is 12.3, implying a prospective dividend yield of 1.7%.
Current consensus EPS estimate suggests the PER is 42.1.

This company reports in NZD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

ANZ    ANZ GROUP HOLDINGS LIMITED

Banks – Overnight Price: $36.77

Jarden rates ((ANZ)) as Overweight (2) –

Jarden expects modest net interest margin (NIM) compression of -1-3bps half-on-half across the major banks in the upcoming results season, with Treasury and Markets strength in the third quarter unlikely to continue into the fourth.

The broker notes strong lending volumes but intensifying competition as lagging banks sharpen pricing to regain share and leaders defend positions. Business banking remains fiercely contested, while success in both proprietary and broker channels remains key.

Despite rising business insolvencies, actual loan losses remain limited, notes the broker, due to low unemployment, high asset prices, and ongoing forbearance.

Jarden prefers Overweight-rated ANZ Bank over Westpac ((WBC)) and National Australia Bank ((NAB)), both rated Underweight.

The target for ANZ Bank is $34.

In the broker’s research excerpt, CommBank ((CBA)) goes unmentioned. Jarden’s latest target and rating in the FNArena database for the bank are $100 and Sell, respectively.

This report was published on October 15, 2025.

Target price is $34.00 Current Price is $36.77 Difference: minus $2.77 (current price is over target).
If ANZ meets the Jarden target it will return approximately minus 8% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $31.62, suggesting downside of -14.0%(ex-dividends)
The company’s fiscal year ends in September.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 166.00 cents.
At the last closing share price the estimated dividend yield is 4.51%.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 214.2, implying annual growth of -1.7%.
Current consensus DPS estimate is 164.0, implying a prospective dividend yield of 4.5%.
Current consensus EPS estimate suggests the PER is 17.2.

Forecast for FY26:

Jarden forecasts a full year FY26 dividend of 166.00 cents.
At the last closing share price the estimated dividend yield is 4.51%.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 236.9, implying annual growth of 10.6%.
Current consensus DPS estimate is 154.4, implying a prospective dividend yield of 4.2%.
Current consensus EPS estimate suggests the PER is 15.5.

Market Sentiment: -0.3
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

ARL    ARDEA RESOURCES LIMITED

Nickel – Overnight Price: $0.63

Petra Capital rates ((ARL)) as Buy (1) –

Petra Capital reiterates Ardea Resources holds a globally significant asset in the Kalgoorlie Nickel Project (KNP), hosting 853.5mt at 0.71% nickel for 6.1mt contained metal.

Positioned as one of only two top-10 nickel deposits outside Russia, Indonesia, and China, KNP offers scale, long life, low costs, and strong ESG credentials, explains the analyst.

Petra notes joint venture partners Sumitomo Metal Mining Co and Mitsubishi Corporation will own 35% post-the definitive feasibility study (DFS) and 50% on final investment decision (FID).

With nickel stabilising around US$15,000/t, the analyst feels supply cuts may tighten the market, supporting prices.

Petra Capital raises its target price to 89c from 84c and maintains a Buy rating.

This report was published on October 16, 2025.

Target price is $0.89 Current Price is $0.63 Difference: $0.26
If ARL meets the Petra Capital target it will return approximately 41% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.

Forecast for FY26:

Petra Capital forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 3.50 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 18.00.

Forecast for FY27:

Petra Capital forecasts a full year FY27 dividend of 0.00 cents and EPS of minus 2.40 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 26.25.

All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

BLX    BEACON LIGHTING GROUP LIMITED

Furniture & Renovation – Overnight Price: $3.00

Jarden rates ((BLX)) as Overweight (2) –

Beacon Lighting reported softer first quarter trading, observes Jarden, with AGM commentary indicating slower store sales momentum from late August through September.

The broker attributes the weakness in retail to a subdued housing market, Reserve Bank of Australia policy uncertainty, and customers delaying purchases ahead of promotional periods. Positively, trade sales continue to grow.

The analyst expects a cyclical housing recovery from FY27, positioning Beacon well to benefit from improved demand and operating leverage when the cycle turns.

The broker lowers its target price to $3.40 from $3.60 on reduced earnings forecasts and retains an Overweight rating.

This report was published on October 15, 2025.

Target price is $3.40 Current Price is $3.00 Difference: $0.4
If BLX meets the Jarden target it will return approximately 13% (excluding dividends, fees and charges).
Current consensus price target is $3.82, suggesting upside of 27.2%(ex-dividends)

Forecast for FY26:

Current consensus EPS estimate is 13.7, implying annual growth of 6.1%.
Current consensus DPS estimate is 8.4, implying a prospective dividend yield of 2.8%.
Current consensus EPS estimate suggests the PER is 21.9.

Forecast for FY27:

Current consensus EPS estimate is 15.7, implying annual growth of 14.6%.
Current consensus DPS estimate is 9.5, implying a prospective dividend yield of 3.2%.
Current consensus EPS estimate suggests the PER is 19.1.

Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

BOQ    BANK OF QUEENSLAND LIMITED

Banks – Overnight Price: $7.18

Jarden rates ((BOQ)) as Sell (5) –

Bank of Queensland’s FY25 cash profit of $383m, was a 12% rise half-on-half and in line with guidance. The net interest margin (NIM) of 1.70% was 2bps ahead of Jarden’s expectation.

The broker points to ongoing, intense competition and highlights Bank of Queensland’s structural disadvantage from weak liability spreads.

Management is reallocating capital from home loans into higher-yielding, higher-risk business lending while pursuing retail digitisation to lower costs and rebuild mortgage margins, explains the analyst.

Jarden remains sceptical of the bank’s ability to outperform peers amid similar strategic shifts. The broker’s near-term earnings forecasts are cut by -4-7%. Sell rating and $6.00 target price are maintained.

This report was published on October 16, 2025.

Target price is $6.00 Current Price is $7.18 Difference: minus $1.18 (current price is over target).
If BOQ meets the Jarden target it will return approximately minus 16% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $6.55, suggesting downside of -8.7%(ex-dividends)

Forecast for FY26:

Current consensus EPS estimate is 55.2, implying annual growth of 173.1%.
Current consensus DPS estimate is 38.8, implying a prospective dividend yield of 5.4%.
Current consensus EPS estimate suggests the PER is 13.0.

Forecast for FY27:

Current consensus EPS estimate is 57.6, implying annual growth of 4.3%.
Current consensus DPS estimate is 40.4, implying a prospective dividend yield of 5.6%.
Current consensus EPS estimate suggests the PER is 12.5.

Market Sentiment: -0.5
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

BRI    BIG RIVER INDUSTRIES LIMITED

Building Products & Services – Overnight Price: $1.42

Petra Capital rates ((BRI)) as Buy (1) –

According to Petra Capital, Big River Industries remains well positioned amid improving housing activity. Annualised commencements in the September 2025 quarter jumped by 12% year-on-year to 178,400.

This quarter marks the first time in seven quarters commencements exceeded completions, highlights the broker, reflecting a stronger run rate in both single-and multi-family construction.

Approvals rose 11.2% year-on-year, with single-family approvals up 3.2%. The latter is key for Big River Industries, notes the analyst.

Petra Capital expects the company’s earnings will rise as residential construction recovers, supported by a strong balance sheet and market position.

The broker retains a Buy rating and a $1.82 target price.

This report was published on October 16, 2025.

Target price is $1.82 Current Price is $1.42 Difference: $0.4
If BRI meets the Petra Capital target it will return approximately 28% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.

Forecast for FY26:

Petra Capital forecasts a full year FY26 dividend of 4.00 cents and EPS of 6.30 cents.
At the last closing share price the estimated dividend yield is 2.82%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 22.54.

Forecast for FY27:

Petra Capital forecasts a full year FY27 dividend of 7.50 cents and EPS of 11.80 cents.
At the last closing share price the estimated dividend yield is 5.28%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 12.03.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

CEN    CONTACT ENERGY LIMITED

Infrastructure & Utilities – Overnight Price: $8.04

Jarden rates ((CEN)) as Overweight (2) –

Contact Energy’s September quarter operating statistics imply to Jarden earnings (EBITDA) of around NZ$100m versus the broker’s prior NZ$81m estimate, aided by NZ$13m in insurance proceeds.

The result compares favourably with NZ$85m in September 2024, driven by higher geothermal and hydro generation, firm retail and commercial margins, and lower costs, explains the broker.

The company’s minority stake in renewable electricity generator Manawa Energy added NZ$15m in September and NZ$40m year-to-date, highlights the analyst.

Jarden maintains an Overweight rating and NZ$10.76 target price.

This report was published on October 16, 2025.

Current Price is $8.04. Target price not assessed.
The company’s fiscal year ends in June.

Forecast for FY26:

Jarden forecasts a full year FY26 dividend of 36.37 cents and EPS of 28.64 cents.
At the last closing share price the estimated dividend yield is 4.52%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 28.07.

Forecast for FY27:

Jarden forecasts a full year FY27 dividend of 38.19 cents and EPS of 30.37 cents.
At the last closing share price the estimated dividend yield is 4.75%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 26.48.

This company reports in NZD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

CPU    COMPUTERSHARE LIMITED

Diversified Financials – Overnight Price: $37.10

Jarden rates ((CPU)) as Upgrade to Overweight from Neutral (2) –

Jarden believes Computershare is positioned for renewed growth despite a softer margin income outlook as global cash rates moderate. Margin income is expected to trough in FY27 before improving in later years.

A 48% increase in global deal activity and stronger US debt markets are supporting underlying earnings (EBIT ex-margin income).

Low gearing versus management’s target is seen as providing capacity for up to 20% earnings accretion if debt capacity is deployed.

Jarden highlights the stock’s de-rating since the FY25 result, with its PE multiple now around -18% below the 10-year average.

The broker raises its target price to $38.50 from $36.50, reflecting modest earnings revisions, and upgrades to Overweight from Neutral.

This report was published on October 15, 2025.

Target price is $38.50 Current Price is $37.10 Difference: $1.4
If CPU meets the Jarden target it will return approximately 4% (excluding dividends, fees and charges).
Current consensus price target is $38.05, suggesting upside of 2.6%(ex-dividends)
The company’s fiscal year ends in June.

Forecast for FY26:

Jarden forecasts a full year FY26 dividend of 106.60 cents.
At the last closing share price the estimated dividend yield is 2.87%.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 212.5, implying annual growth of N/A.
Current consensus DPS estimate is 99.3, implying a prospective dividend yield of 2.7%.
Current consensus EPS estimate suggests the PER is 17.5.

Forecast for FY27:

Jarden forecasts a full year FY27 dividend of 107.00 cents.
At the last closing share price the estimated dividend yield is 2.88%.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 219.3, implying annual growth of 3.2%.
Current consensus DPS estimate is 102.8, implying a prospective dividend yield of 2.8%.
Current consensus EPS estimate suggests the PER is 16.9.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: -0.1
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

EGG    ENERO GROUP LIMITED

Media – Overnight Price: $0.69

Canaccord Genuity rates ((EGG)) as Buy (1) –

Canaccord Genuity highlights Enero Group’s 1Q26 update pointed to the robust nature of the Australian agencies, with continuing issues confronting its largest business, Hotwire, which has resulted in the analyst downgrading the FY26 revenue forecast by -14%.

The previous CEO of Hotwire left the business in July, and Enero has appointed a new CEO who will be announced soon, with a start date in January 2026.

Net revenue grew 1%, with earnings (EBITDA) up 13% on the prior year, while operating costs rose $0.3m on the previous year. BMF Creative Agency revenue lifted 18% from recent client wins.

No change in Buy rating. Target falls to $1.30 from $1.45.

This report was published on October 15, 2025.

Target price is $1.30 Current Price is $0.69 Difference: $0.605
If EGG meets the Canaccord Genuity target it will return approximately 87% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.

Forecast for FY26:

Canaccord Genuity forecasts a full year FY26 dividend of 2.75 cents and EPS of 5.50 cents.
At the last closing share price the estimated dividend yield is 3.96%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 12.64.

Forecast for FY27:

Canaccord Genuity forecasts a full year FY27 dividend of 3.36 cents and EPS of 6.70 cents.
At the last closing share price the estimated dividend yield is 4.83%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 10.37.

All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

ERD    EROAD LIMITED

Transportation & Logistics – Overnight Price: $1.60

Jarden rates ((ERD)) as Downgrade to Underweight from Neutral (4) –

Eroad is set to benefit from the New Zealand’ government’s transition to a GPS-based electronic road user charge (eRUC) system, with the company well positioned to service the light vehicle fleet, according to Jarden.

The broker estimates the eRUC opportunity could generate about NZ$138m in annual revenue, though the final framework will depend on legislation expected in 2026.

Jarden incorporates the eRUC upside into its valuation, lifting its target price to NZ$2.30 from NZ$1.20, including NZ$0.91 of value from the eRUC potential.

Given the recent share price re-rating since the government announcement, Jarden downgrades Eroad to Underweight from Neutral.

This report was published on October 16, 2025.

Current Price is $1.60. Target price not assessed.
The company’s fiscal year ends in March.

Forecast for FY26:

Jarden forecasts a full year FY26 dividend of 0.00 cents.

Forecast for FY27:

Jarden forecasts a full year FY27 dividend of 0.00 cents.

This company reports in NZD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

EVN    EVOLUTION MINING LIMITED

Gold & Silver – Overnight Price: $11.10

Jarden rates ((EVN)) as Underweight (4) –

Evolution Mining’s September quarter gold production of 174koz was -6.5% below the consensus estimate due to weather impacts at Cowal and downtime at Ernest Henry, explains Jarden.

All operations remain on track for FY26 guidance, suggests the broker, supported by record net mine cash flow of $366m and a rising gold price.

At current spot levels near $6,450/oz, the analyst estimates FY26 operating mine cash flow could reach $3.5bn.

The balance sheet continues to deleverage rapidly, highlights Jarden, with gearing near 10%. A capital management update is expected early 2026.

Jarden raises its target price to $6.70 from $6.05 and maintains an Underweight rating.

This report was published on October 16, 2025.

Target price is $6.70 Current Price is $11.10 Difference: minus $4.4 (current price is over target).
If EVN meets the Jarden target it will return approximately minus 40% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $9.81, suggesting downside of -11.6%(ex-dividends)
The company’s fiscal year ends in June.

Forecast for FY26:

Jarden forecasts a full year FY26 dividend of 14.00 cents.
At the last closing share price the estimated dividend yield is 1.26%.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 81.5, implying annual growth of 75.3%.
Current consensus DPS estimate is 38.2, implying a prospective dividend yield of 3.4%.
Current consensus EPS estimate suggests the PER is 13.6.

Forecast for FY27:

Jarden forecasts a full year FY27 dividend of 23.00 cents.
At the last closing share price the estimated dividend yield is 2.07%.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 76.1, implying annual growth of -6.6%.
Current consensus DPS estimate is 42.1, implying a prospective dividend yield of 3.8%.
Current consensus EPS estimate suggests the PER is 14.6.

Market Sentiment: -0.4
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

FCL    FINEOS CORPORATION HOLDINGS PLC

Cloud services – Overnight Price: $3.06

Canaccord Genuity rates ((FCL)) as Initiation of coverage with Buy (1) –

Canaccord Genuity initiates coverage of Fineos Corp with a Buy rating and $3.45 target price. The company is described as a leading provider of insurance software to Life, Accident and Health insurers worldwide and is based in Dublin.

The analyst considers the unit economics to be “attractive,” with its software experiencing negligible churn rates of 1-2%, long-term customer relations averaging ten years, and gross margins over 75%.

Canaccord believes Fineos is at an “inflection” point in its profitability and on the way to generating positive free cash flow, supported by a robust and improving pipeline of new, upsell, and cross-sell customers.

This report was published on October 15, 2025.

Target price is $3.45 Current Price is $3.06 Difference: $0.39
If FCL meets the Canaccord Genuity target it will return approximately 13% (excluding dividends, fees and charges).
The company’s fiscal year ends in December.

Forecast for FY25:

Canaccord Genuity forecasts a full year FY25 EPS of 1.55 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 197.16.

Forecast for FY26:

Canaccord Genuity forecasts a full year FY26 EPS of 2.07 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 147.90.

This company reports in EUR. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

GEM    G8 EDUCATION LIMITED

Childcare – Overnight Price: $0.81

Moelis rates ((GEM)) as Hold (3) –

Relevant to the G8 Education business, Moelis highlights Australia’s fertility rate continues to decline, falling to 1.48 births per woman in 2025 from 1.50 in 2023. More positively, total births rose 1.9% to 292,318, the first increase since 2021.

Immigration remains elevated, with a net gain of 445,640 people in FY24, largely younger cohorts, which supports childcare demand despite slower natural growth.

Long day care supply grew 3.5% year-on-year to 9,465 centres, while improving real wages (+1.3% in June 2025) may help offset cost-of-living pressures.

G8 Education is expected to benefit from gradually improving enquiry, enrolment, and occupancy trends.

Target 92c. Hold.

This report was published on October 16, 2025.

Target price is $0.92 Current Price is $0.81 Difference: $0.115
If GEM meets the Moelis target it will return approximately 14% (excluding dividends, fees and charges).

Market Sentiment: 0.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

JIN    JUMBO INTERACTIVE LIMITED

Gaming – Overnight Price: $12.68

Jarden rates ((JIN)) as Buy (1) –

Jumbo Interactive has acquired UK-based prize draw operator Dream Car Giveaways for -$110m, marking its largest acquisition and first direct-to-consumer expansion offshore, highlights Jarden.

Over FY26-29, the broker expects the deal to lift group earnings (EBITDA) and earnings per share after amortisation (EPSA) by an average 23% and 15%, respectively.

The acquisition meaningfully diversifies Jumbo’s earnings base beyond Australian lotteries, highlights the broker, reducing volatility tied to jackpot cycles.

Greater scale is also thought to reduce renewal risk for its reseller agreement with Lottery Corp ((TLC) expiring in 2030.

Jarden raises its target price to $14.10 from $13.20 and maintains a Buy rating.

This report was published on October 16, 2025.

Target price is $14.10 Current Price is $12.68 Difference: $1.42
If JIN meets the Jarden target it will return approximately 11% (excluding dividends, fees and charges).
Current consensus price target is $13.56, suggesting upside of 6.9%(ex-dividends)

Forecast for FY26:

Current consensus EPS estimate is 75.8, implying annual growth of 18.2%.
Current consensus DPS estimate is 52.3, implying a prospective dividend yield of 4.1%.
Current consensus EPS estimate suggests the PER is 16.7.

Forecast for FY27:

Current consensus EPS estimate is 89.3, implying annual growth of 17.8%.
Current consensus DPS estimate is 62.9, implying a prospective dividend yield of 5.0%.
Current consensus EPS estimate suggests the PER is 14.2.

Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

MTM    METALLIUM LIMITED

Industrial Metals – Overnight Price: $1.03

Petra Capital rates ((MTM)) as Buy (1) –

Petra Capital highlights Metallium has achieved over 90% recovery of rare earths from NdFeB magnet scrap using its Flash Joule Heating (FJH) process. NdFeB stands for neodymium-iron-boron, a type of rare earth permanent magnet.

Global rare earth element (REE) magnet demand is forecast to double by 2035, highlights the broker, driven by EV and wind technology.

The company will now test the method at its 350tpa Texas facility, notes the analyst, extending its e-waste expertise into magnet recycling.

With recycled magnets forecast to supply up to 25% of rare earth demand by the early 2030s, Metallium’s results strengthen its strategic position, in the analyst’s view.

Petra Capital retains a Buy rating and $1.40 target price.

This report was published on October 16, 2025.

Target price is $1.40 Current Price is $1.03 Difference: $0.37
If MTM meets the Petra Capital target it will return approximately 36% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.

Forecast for FY26:

Petra Capital forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 1.80 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 57.22.

Forecast for FY27:

Petra Capital forecasts a full year FY27 dividend of 0.00 cents and EPS of 2.70 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 38.15.

All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

NDO    NIDO EDUCATION LIMITED

Childcare – Overnight Price: $0.63

Moelis rates ((NDO)) as Buy (1) –

Relevant to the Nido Education business, Moelis highlights Australia’s fertility rate continues to decline, falling to 1.48 births per woman in 2025 from 1.50 in 2023. More positively, total births rose 1.9% to 292,318, the first increase since 2021.

Immigration remains elevated, with a net gain of 445,640 people in FY24, largely younger cohorts, which supports childcare demand despite slower natural growth.

Long day care supply grew 3.5% year-on-year to 9,465 centres, while improving real wages (+1.3% in June 2025) may help offset cost-of-living pressures.

Nido Education is expected to benefit from gradually improving enquiry, enrolment, and occupancy trends.

Target $1.03. Buy.

This report was published on October 16, 2025.

Target price is $1.03 Current Price is $0.63 Difference: $0.4
If NDO meets the Moelis target it will return approximately 63% (excluding dividends, fees and charges).
The company’s fiscal year ends in December.

Forecast for FY25:

Moelis forecasts a full year FY25 dividend of 4.40 cents and EPS of 6.40 cents.
At the last closing share price the estimated dividend yield is 6.98%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 9.84.

Forecast for FY26:

Moelis forecasts a full year FY26 dividend of 5.70 cents and EPS of 8.70 cents.
At the last closing share price the estimated dividend yield is 9.05%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 7.24.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

ORA    ORORA LIMITED

Paper & Packaging – Overnight Price: $2.01

Jarden rates ((ORA)) as Buy (1) –

In a 1Q trading update, management at Orora reiterated FY26 guidance for earnings (EBITDA) and cash flow growth across all divisions, a key confidence boost following prior volatility, suggests Jarden.

The broker notes first quarter Cans performance was in line with expectations, while the Gawler facility remains on track to deliver around $30m in FY26 earnings (EBIT), consistent with consensus.

Saverglass continues to drive sentiment, notes the broker, with management guiding to lower first-half earnings and a stronger second-half skew, matching Jarden’s forecasts.

Jarden maintains its Buy rating and $2.60 target price.

This report was published on October 16, 2025.

Target price is $2.60 Current Price is $2.01 Difference: $0.59
If ORA meets the Jarden target it will return approximately 29% (excluding dividends, fees and charges).
Current consensus price target is $2.28, suggesting upside of 13.6%(ex-dividends)
The company’s fiscal year ends in June.

Forecast for FY26:

Jarden forecasts a full year FY26 dividend of 10.10 cents and EPS of 13.60 cents.
At the last closing share price the estimated dividend yield is 5.02%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 14.78.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 13.6, implying annual growth of 26.4%.
Current consensus DPS estimate is 9.9, implying a prospective dividend yield of 4.9%.
Current consensus EPS estimate suggests the PER is 14.8.

Forecast for FY27:

Jarden forecasts a full year FY27 dividend of 12.50 cents and EPS of 16.80 cents.
At the last closing share price the estimated dividend yield is 6.22%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 11.96.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 14.7, implying annual growth of 8.1%.
Current consensus DPS estimate is 10.9, implying a prospective dividend yield of 5.4%.
Current consensus EPS estimate suggests the PER is 13.7.

Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

SPG    SPC GLOBAL HOLDINGS LIMITED

Food, Beverages & Tobacco – Overnight Price: $0.47

Canaccord Genuity rates ((SPG)) as Initiation of coverage with Buy (1) –

Canaccord Genuity initiates coverage of SPC Global with a Buy rating and 85c target price.

The company is a leader in the Australian food and beverage sector and the result of the merger between SPC, The Original Juice Co, Nature One Dairy and Natural Ingredients in late 2024.

The company appears to have robust operational scale with a “strong” brand portfolio and optionality around generating cost savings and synergies. The analyst estimates management’s ability to achieve targets could result in earnings (EBITDA) doubling over the next three years.

Debt remains an issue, and Canaccord views concerns over leverage, illiquidity of shares post-relisting, and some “trapped” holders on the share register, as well as risks around operating and integration, could be compressing the stock’s valuation.

This report was published on October 15, 2025.

Target price is $0.85 Current Price is $0.47 Difference: $0.385
If SPG meets the Canaccord Genuity target it will return approximately 83% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.

Forecast for FY26:

Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 3.02 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 15.40.

Forecast for FY27:

Canaccord Genuity forecasts a full year FY27 dividend of 0.00 cents and EPS of 1.77 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 26.27.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

TLX    TELIX PHARMACEUTICALS LIMITED

Pharmaceuticals & Biotech/Lifesciences – Overnight Price: $16.50

Canaccord Genuity rates ((TLX)) as Buy (1) –

Telix Pharmaceuticals’ 3Q25 global Illucix sales of US$155m were up 17% y/y and beat Canaccord Genuity’s forecast of US$152m, though missed consensus of US$157m. 3Q25 group revenue came in at US$206m, up 53% y/y.

The company upgraded FY25 revenue guidance to US$800-820m from US$770-800m, compared with the broker’s forecast of US$800m. The broker reckons this shouldn’t come as a surprise following Gozellix’s reimbursement from October 1.

Potential upside exists from additional market share gains in the US regional outpatient centres using 68Ga scans. The broker upgraded FY25 revenue forecast to US$813.5m.

Attention is now on a potential 4Q beat and TLX591 safety data, which could shape the company’s long-term growth outlook, the broker highlights.

Buy. Target rises to $27.41 from $27.33.

This report was published on October 15, 2025.

Target price is $27.41 Current Price is $16.50 Difference: $10.91
If TLX meets the Canaccord Genuity target it will return approximately 66% (excluding dividends, fees and charges).
Current consensus price target is $27.20, suggesting upside of 64.8%(ex-dividends)
The company’s fiscal year ends in December.

Forecast for FY25:

Canaccord Genuity forecasts a full year FY25 dividend of 0.00 cents and EPS of minus 13.24 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 124.59.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is -1.9, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is N/A.

Forecast for FY26:

Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 24.76 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 66.64.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 10.2, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 161.8.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

Jarden rates ((TLX)) as Buy (1) –

Telix Pharmaceuticals delivered an encouraging third quarter, in Jarden’s opinion, with group and PSMA imaging revenue both up 1% sequentially.

Fears of a revenue gap following the loss of Illuccix’s transitional pass-through (TPT) status did not materialise, as a 3% increase in dose volume offset only a -2% price decline.

Earlier discounting helped secure market share, explains Jarden, positioning Telix well for a stronger fourth quarter now that Gozellix has gained TPT reimbursement, effective October 2025.

2025 revenue guidance was upgraded to US$800-820m, up 3% at the midpoint.

Jarden retains a Buy rating and sets a $28.06 target price, down from $28.13.

This report was published on October 16, 2025.

Target price is $28.06 Current Price is $16.50 Difference: $11.56
If TLX meets the Jarden target it will return approximately 70% (excluding dividends, fees and charges).
Current consensus price target is $27.20, suggesting upside of 64.8%(ex-dividends)
The company’s fiscal year ends in December.

Forecast for FY25:

Jarden forecasts a full year FY25 dividend of 0.00 cents and EPS of minus 1.87 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 883.77.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is -1.9, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is N/A.

Forecast for FY26:

Jarden forecasts a full year FY26 dividend of 0.00 cents and EPS of 16.03 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 102.94.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 10.2, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 161.8.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

TTM    TITAN MINERALS LIMITED

Gold & Silver – Overnight Price: $0.57

Canaccord Genuity rates ((TTM)) as Speculative Buy (1) –

Titan Minerals secured a US$10m strategic investment from Lingbao Gold International Company, which will acquire 25.8m new shares at a 33% premium ($0.59/share), taking a 9.9% stake.

Canaccord Genuity notes the funding will accelerate drilling and de-risking of the Dynasty Gold Project, with potential downstream synergies from Lingbao’s gold-silver processing facilities in China.

Settlement is set for 22 October, with Lingbao granted 90-day exclusivity and a 180-day right of first refusal on any Dynasty sale or farm-out.

The broker notes  Dynasty’s drilling program is advancing toward a resource update by end-2025, with a Scoping Study expected in 1H26.

Speculative Buy. Target unchanged at $1.55.

This report was published on October 15, 2025.

Target price is $1.55 Current Price is $0.57 Difference: $0.98
If TTM meets the Canaccord Genuity target it will return approximately 172% (excluding dividends, fees and charges).
The company’s fiscal year ends in December.

Forecast for FY25:

Canaccord Genuity forecasts a full year FY25 dividend of 0.00 cents and EPS of minus 0.30 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 190.00.

Forecast for FY26:

Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 0.20 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 285.00.

All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

Disclaimer:
The content of this information does in no way reflect the opinions of FNArena, or of its journalists. In fact we don’t have any opinion about the stock market, its value, future direction or individual shares. FNArena solely reports about what the main experts in the market note, believe and comment on. By doing so we believe we provide experienced, intelligent investors with a valuable tool that helps them in making up their own minds, reading market trends and getting a feel for what is happening beneath the surface.

This document is provided for informational purposes only. It does not constitute an offer to sell or a solicitation to buy any security or other financial instrument. FNArena employs very experienced journalists who base their work on information believed to be reliable and accurate, though no guarantee is given that the daily report is accurate or complete. Investors should contact their personal adviser before making any investment decision.

Click to view our Glossary of Financial Terms